NS 200
Alternative Names: NS-200Latest Information Update: 26 May 2021
At a glance
- Originator Neuracle Science
- Class Irritable bowel syndrome therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Gastrointestinal disorders; Irritable bowel syndrome
Most Recent Events
- 19 May 2021 Preclinical trials in Gastrointestinal disorders in South Korea (unspecified route) before May 2021 (Neuracle Science pipeline, May 2021)
- 19 May 2021 Preclinical trials in Irritable bowel syndrome in South Korea (unspecified route) before May 2021 (Neuracle Science pipeline, May 2021)